548 related articles for article (PubMed ID: 25458789)
1. Colon cancer: cancer stem cells markers, drug resistance and treatment.
Kozovska Z; Gabrisova V; Kucerova L
Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
[TBL] [Abstract][Full Text] [Related]
2. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
Xie ZY; Lv K; Xiong Y; Guo WH
Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
[TBL] [Abstract][Full Text] [Related]
3. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
4. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
Mohammad IS; He W; Yin L
Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
6. Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays.
Warrier S; Pavanram P; Raina D; Arvind M
Cell Biol Int; 2012; 36(12):1137-43. PubMed ID: 22770475
[TBL] [Abstract][Full Text] [Related]
7. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
[TBL] [Abstract][Full Text] [Related]
8. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the ABCs of multidrug resistance in cancer chemotherapy.
Tiwari AK; Sodani K; Dai CL; Ashby CR; Chen ZS
Curr Pharm Biotechnol; 2011 Apr; 12(4):570-94. PubMed ID: 21118094
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
12. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
McIntosh K; Balch C; Tiwari AK
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
[TBL] [Abstract][Full Text] [Related]
13. Reversing agents for ATP-binding cassette drug transporters.
Lee CH
Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
[TBL] [Abstract][Full Text] [Related]
14. Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells.
Guo P; Wang J; Gao W; Liu X; Wu S; Wan B; Xu L; Li Y
Mol Med Rep; 2018 Aug; 18(2):1323-1334. PubMed ID: 29845279
[TBL] [Abstract][Full Text] [Related]
15. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
17. IL-4-mediated drug resistance in colon cancer stem cells.
Todaro M; Perez Alea M; Scopelliti A; Medema JP; Stassi G
Cell Cycle; 2008 Feb; 7(3):309-13. PubMed ID: 18235245
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
Wei N; Sun H; Liu GT
Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
[TBL] [Abstract][Full Text] [Related]
19. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
[TBL] [Abstract][Full Text] [Related]
20. The ABCs of cancer stem cell drug resistance.
Elliott A; Adams J; Al-Hajj M
IDrugs; 2010 Sep; 13(9):632-5. PubMed ID: 20799146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
